270 related articles for article (PubMed ID: 25978841)
1. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
4. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
Liao KF; Lai SW; Li CI; Chen WC
J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.
Lai SW; Liao KF; Chen PC; Tsai PY; Hsieh DP; Chen CC
Clin Lung Cancer; 2012 Mar; 13(2):143-8. PubMed ID: 22129971
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study.
Lai HC; Lin CC; Cheng KS; Kao JT; Chou JW; Peng CY; Lai SW; Chen PC; Sung FC
Gastroenterology; 2014 Jan; 146(1):129-37.e1. PubMed ID: 24095786
[TBL] [Abstract][Full Text] [Related]
8. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study.
Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC
Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605
[TBL] [Abstract][Full Text] [Related]
9. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
10. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
[TBL] [Abstract][Full Text] [Related]
11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
12. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ; Moss RA
Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
[TBL] [Abstract][Full Text] [Related]
14. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
15. Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study.
Wu SW; Ho YC; Luo CW; Chen HY; Su CH; Kuan YH
Int J Med Sci; 2021; 18(3):778-784. PubMed ID: 33437213
[No Abstract] [Full Text] [Related]
16. [Diabetes and cancer: an injurious association].
Gariani K; Tran C; Philippe J
Rev Med Suisse; 2010 Jun; 6(252):1193-4, 1196-8. PubMed ID: 20614754
[TBL] [Abstract][Full Text] [Related]
17. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
18. Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan.
Ke CC; Lai HC; Lin CH; Hung CJ; Chen DY; Sheu WH; Lui PW
PLoS One; 2016; 11(1):e0146750. PubMed ID: 26751202
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan.
Chen YL; Cheng KC; Lai SW; Tsai IJ; Lin CC; Sung FC; Lin CC; Chen PC
Gastric Cancer; 2013 Jul; 16(3):389-96. PubMed ID: 23053824
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.
Jiang YD; Chang CH; Tai TY; Chen JF; Chuang LM
J Formos Med Assoc; 2012 Nov; 111(11):599-604. PubMed ID: 23217595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
